常快乐 付清海 韩雪玲 于军 王芳.苯那普利联合氯沙坦治疗早期糖尿病肾病的临床研究[J].,2014,14(9):1716-1718 |
苯那普利联合氯沙坦治疗早期糖尿病肾病的临床研究 |
Clinical research on the Effects of Benazepril and Losartan in the treatmentof Type 2 diabetic nephropathy patients |
|
DOI: |
中文关键词: 苯那普利 氯沙坦 糖尿病肾病 高敏C 反应蛋白 脂联素 |
英文关键词: Benazepril Losartan Diabetic nephropathy High sensitivity-C response protein(hs-CRP) Adiponectin(APN) |
基金项目: |
|
摘要点击次数: 642 |
全文下载次数: 1129 |
中文摘要: |
目的:研究苯那普利联合氯沙坦对2 型糖尿病肾病(diabetic nephropathy,DN)患者肾功能以及血浆脂联素(adiponectin,APN)
和高敏C反应蛋白(high sensitivity-C response protein,hs-CRP)的影响。方法:选择我院心血管内科住院的2 型糖尿病肾病患者42
例,均符合早期糖尿病肾病的诊断标准,给予苯那普利10~20mg治疗3 个月后,给予苯那普利10mg 联合氯沙坦50mg~100mg
再治疗3 个月,检测和比较治疗前后患者血肌酐(Scr)和24 小时尿蛋白定量(24h-UPE)以及血浆hs-CRP和APN 水平。结果:苯那
普利治疗3 个月后,患者的Scr、24h-UPE和hs-CRP 水平较治疗前明显降低;血浆APN水平较治疗前明显升高,差异均有统计学
意义(P<0.05)。而苯那普利联合氯沙坦再治疗3 个月后,患者的Scr、24h-UPE 水平和hs-CRP 水平较苯那普利治疗3 月时更低,
血浆APN 水平较苯那普利治疗3个月时更高,差异均有统计学意义(P<0.05)。结论:苯那普利联合氯沙坦治疗可更好地保护早期
糖尿病肾病患者的肾功能,这可能与其提高血浆APN 水平和降低CRP水平有关。 |
英文摘要: |
Objective:To investigate the effect of Benazepril and Losartan on the renal function and serumadiponectin(APN) and
high sensitivity C-reactive protein (hs-CRP) levels of patients with type 2 diabetic nephropathy (DN).Methods:42 patients with type 2
diabetic nephropathy were enrolled in this study. Diabetic nephropathy was defined as the presence of 24h-UPE, We administered a submaximal
dose of benazepril (20mg/day) for 3 months. After 3months, we administered a dose of benazepril (10mg/day) added Losartan
50-100mg/d for 3months. Blood and urine samples were obtained at the baseline, 3 months later, and 6 months later. The plasma
concentrations of APN were determined using ELISAs. Blood lipid and 24h-UPE, Scr and hs-CRP were measured routinely.Data were
compared before and after the treatment.Results:The scr level, hs-CRP and 24h-UPE were significantly decreased after 3 months'
treatment compared with those before treatment (P<0.05). The scr level, hs-CRP and 24h-UPE were significantly decreased after 6
months' treatment compared with those after 3 months' treatment(P<0.05). The serumAPN level was lower in diabetic patients than that
in the healthy control. The serum APN was significantly increased after treatment (P<0.05), which was significantly increased after
6months' treatment compared with those after 3 months treatment (P<0.05).Conclusion:Combined therapy with ACEI and ARB could
better improve the renal function of of patients with type 2 diabetic nephropathy (DN), the increase of serum APN and decrease of CRP
may be involved. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |